What is the management approach for coincidental meningiomas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The majority of coincidental meningiomas, approximately 60-70%, remain stable over many years of follow-up, with only a small percentage showing significant growth. When managing coincidental meningiomas, the approach typically involves observation with regular imaging surveillance rather than immediate intervention, as outlined in guidelines such as those from the Journal of the National Comprehensive Cancer Network 1. Key considerations in the management of these tumors include:

  • Tumor size: Small meningiomas (< 30 mm) are often observed, especially if asymptomatic, while larger ones (≥ 30 mm) may require surgery if accessible, followed by radiation therapy (RT) if they are WHO grade 3c or if there's incomplete resection for WHO grade 1/2 tumors 1.
  • Symptomatology: Symptomatic meningiomas, regardless of size, usually require surgical intervention if accessible, followed by RT for WHO grade 3c tumors or consideration of RT for incomplete resection of WHO grade 1/2 tumors 1.
  • Growth rate: The median growth rate for meningiomas is about 4 mm per annum, but significant growth (>1 cm/year) can prompt a reevaluation of the management plan. Given the slow growth rate of many meningiomas and the risks associated with surgical intervention, a conservative approach with regular monitoring is often preferred for asymptomatic, incidentally discovered meningiomas. This approach allows for the identification of tumors that may require more aggressive management due to growth or the development of symptoms, while minimizing unnecessary interventions and their associated risks for patients with stable, asymptomatic lesions.

From the Research

Management Approach for Coincidental Meningiomas

The management approach for coincidental meningiomas involves several factors, including the risk of complications from surgery, the possibility of malignancies, and the age and medical condition of the patient 2.

Growth Patterns of Incidental Meningiomas

Incidental meningiomas can fall into one of three main growth patterns: no growth, linear growth, or exponential growth 2.

Percentage of Coincidental Meningiomas that Enlarge on Follow-up

  • Approximately 35.4% of incidental meningiomas were found to grow during follow-up, resulting in a 75% 15-year growth rate by life-table statistics 3.
  • The growth rates were similar in smaller (<2 cm) and larger tumors, while calcified tumors grew at a lower rate, although this difference was not statistically significant 3.

Treatment Options

Treatment options for meningiomas include surgical intervention, stereotactic radiosurgery (SRS), and fractionated stereotactic radiotherapy (SRT) 4, 5, 6.

  • SRS is typically used for smaller meningiomas that are considered inoperable or for patients who prefer not to undergo surgery 4.
  • SRT is useful for larger meningiomas or those closely approximating critical structures, such as the optic chiasm and brainstem 5.
  • A systematic review and meta-analysis found that SRT carries a better radiographic tumor control rate and a lower incidence of post-treatment symptomatic worsening and symptomatic edema compared to SRS 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.